title: Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
abstract: We describe the successful use of combined ascitic-fluid and furosemide infusion as a therapeutic option in the management of massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis in a 30-year-old Nigerian male farmer. It is simple, safe, convenient and effective treatment modality. The mechanics of this procedure seen against the backgroup of the pathogenesis of sodium retention and renal dysfunction in hepatic cirrhosis is discussed.
authors.forename: M A
authors.initials: MA
authors.lastname: Onuigbo
authors.forename: J O
authors.initials: JO
authors.lastname: Ozoh
authors.forename: C A
authors.initials: CA
authors.lastname: Nusiem
authors.forename: A C
authors.initials: AC
authors.lastname: Onyeagocha
authors.forename: O
authors.initials: O
authors.lastname: Nwaneri
authors.forename: A A
authors.initials: AA
authors.lastname: Offodile
authors.forename: C K
authors.initials: CK
authors.lastname: Ijoma
mesh_terms: D000328:Adult; D001201:Ascites / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D001202:Ascitic Fluid; D005665:Furosemide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007274:Injections, Intraperitoneal / Q000295:instrumentation / Q000379:methods*; D007275:Injections, Intravenous; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D009846:Oliguria / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*
chemical_list: D005665:Furosemide